{"url":"https://lda.senate.gov/api/v1/filings/09c8b2fd-9e75-4662-90f2-604ea674be36/","filing_uuid":"09c8b2fd-9e75-4662-90f2-604ea674be36","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2014,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/09c8b2fd-9e75-4662-90f2-604ea674be36/print/","filing_document_content_type":"text/html","income":"100000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Daniel R. Murphy, General Counsel","dt_posted":"2014-10-20T17:58:40.120000-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"601 Thirteenth Street, NW","registrant_address_2":"Eleventh Floor South","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":5357,"url":"https://lda.senate.gov/api/v1/registrants/5357/","house_registrant_id":31564,"name":"BGR GOVERNMENT AFFAIRS","description":"Lobbying firm","address_1":"601 13th Street, NW","address_2":"11th Floor South","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"CHELSEA MINCHEFF","contact_telephone":"+1 202-661-6385","dt_updated":"2026-01-30T13:07:06.930629-05:00"},"client":{"id":106642,"url":"https://lda.senate.gov/api/v1/clients/106642/","client_id":1006512,"name":"DEA SCHEDULING COALITION (INFORMAL COALITION)","general_description":"DEA scheduling of FDA approved products","client_government_entity":false,"client_self_select":null,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2014-01-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Provide guidance and strategic counsel with regard to DEA scheduling of FDA approved products.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":58039,"prefix":null,"prefix_display":null,"first_name":"RYAN","nickname":null,"middle_name":null,"last_name":"LONG","suffix":null,"suffix_display":null},"covered_position":"See prior filing","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}